ReP USP - Resultado da busca

Filtros : "Haerynck, Filomeen" Removidos: "Grécia" "Financiamento NCI" Limpar

Filtros

Indexado em
Collaboration
Normalized affiliation
Non normalized affiliation
- allergy and clinical immunology unit, department of medicine, tel aviv sourasky medical center and sackler faculty of medicine, tel aviv, israel (1)
- ankara university school of medicine, department of pediatric immunology and allergy, ankara, turkey (1)
- ankara university school of medicine. department of pediatric immunology and allergy, ankara, turkey (1)
- centre for primary immunodeficiency, department of pediatric pulmonoly and immunology, ghent university hospital, belgium (1)
- clinical immunology unit, p1, ibn rush hospital, laboratoire d´immunologie clinique, inflammation et allergie licia and medicine and pharmacy faculty of hassan ii university, casablanca, morocco (1)

Countries of institutions of collaboration
- bélgica (2)
- canadá (2)
- espanha (2)
- estados unidos (2)
- itália (2)

Artigo de periodico-carta/editorial
Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β (2021)
Vinh, Donald C. ; Abel, Laurent ; Bastard, Paul ; Cheng, Matthew P. ; Condino Neto, Antonio ; Gregersen, Peter K. ; Haerynck, Filomeen ; Cicalese, Maria-Pia ; Hagin, David; Palacín, Pere Soler ; Planas, Anna M. ; Pujol, Aurora ; Notarangelo, Luigi D. ; Zhang, Qian ; Su, Helen C. ; Casanova, Jean-Laurent ; Meyts, Isabelle
Source: Journal of Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNIDADE, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGENÉTICA, COVID-19, INTERFERON TIPO I, INFECÇÕES POR CORONAVIRUS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINH, Donald C. et al. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s10875-021-01068-6. Acesso em: 01 nov. 2024. , 2021
APA
Vinh, D. C., Abel, L., Bastard, P., Cheng, M. P., Condino Neto, A., Gregersen, P. K., et al. (2021). Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1007/s10875-021-01068-6
NLM
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Vancouver
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Artigo de periodico
X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world (2019)
El-Sayed, Zeinab A. ; Abramova, Irina ; Aldave, Juan Carlos ; Al-Herz, Waleed ; Bezrodnik, Liliana ; Boukari, Rachida ; Bousfilha, Ahmed Aziz; Cancrini, Caterina ; Dbaibo, Ghassan ; Derfalvi, Beata; Dogu, Figen ; Edgar, J. Davi M.; Eley, Brian ; El-Owaidy, Rasha Hasan ; Espinosa-Padilla, Sara Elva; Galal, Nermeen ; Haerynck, Filomeen ; Hanna-Wakim, Rima ; Hossny, Elham ; Ikinciogullari, Aydan ; Kamal, Ebtihal; Kanegane, Hirokaku ; Kechout, Nadia ; Lau, Yu Lung ; Morio, Tomohiro; Moschese, Viviana ; Neves, João Farela ; Quederni, Monia; Paganelli, Roberto ; Paris, Kenneth ; Pignata, Claudia; Plebani, Alessandro ; Qamar, Farah Naz; Qureshi, Sonia ; Radhakrishnan, Nita ; Rezaei, Nima; Rosario, Nelson ; Routes, John ; Sanchez, Berta; Sediva, Anna ; Seppanen, Mikko Risto Juhana ; Serrano, Edith Gonzalez ; Shcherbina, Anna ; Singh, Surjit ; Siniah, Sangeetha; Spadaro, Guiseppe; Tang, Mimi ; Vinet, Ana Maria; Volokha, Alla ; Sullivan, Kathleen E. ; Condino Neto, Antonio
Source: World Allergy Organization Journal. Unidade: ICB
Subjects: FENÓTIPOS, AGAMAGLOBULINEMIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGLOBULINAS, GENÉTICA APLICADA, ALERGIA E IMUNOLOGIA, VACINAS, LINFÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EL-SAYED, Zeinab A. et al. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organization Journal, v. 12, p. 9 , 2019Tradução . . Disponível em: https://doi.org/10.1016/j.waojou.2019.100018. Acesso em: 01 nov. 2024.
APA
El-Sayed, Z. A., Abramova, I., Aldave, J. C., Al-Herz, W., Bezrodnik, L., Boukari, R., et al. (2019). X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organization Journal, 12, 9 . doi:10.1016/j.waojou.2019.100018
NLM
El-Sayed ZA, Abramova I, Aldave JC, Al-Herz W, Bezrodnik L, Boukari R, Bousfilha AA, Cancrini C, Dbaibo G, Derfalvi B, Dogu F, Edgar JDM, Eley B, El-Owaidy RH, Espinosa-Padilla SE, Galal N, Haerynck F, Hanna-Wakim R, Hossny E, Ikinciogullari A, Kamal E, Kanegane H, Kechout N, Lau YL, Morio T, Moschese V, Neves JF, Quederni M, Paganelli R, Paris K, Pignata C, Plebani A, Qamar FN, Qureshi S, Radhakrishnan N, Rezaei N, Rosario N, Routes J, Sanchez B, Sediva A, Seppanen MRJ, Serrano EG, Shcherbina A, Singh S, Siniah S, Spadaro G, Tang M, Vinet AM, Volokha A, Sullivan KE, Condino Neto A. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world [Internet]. World Allergy Organization Journal. 2019 ; 12 9 .[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.waojou.2019.100018
Vancouver
El-Sayed ZA, Abramova I, Aldave JC, Al-Herz W, Bezrodnik L, Boukari R, Bousfilha AA, Cancrini C, Dbaibo G, Derfalvi B, Dogu F, Edgar JDM, Eley B, El-Owaidy RH, Espinosa-Padilla SE, Galal N, Haerynck F, Hanna-Wakim R, Hossny E, Ikinciogullari A, Kamal E, Kanegane H, Kechout N, Lau YL, Morio T, Moschese V, Neves JF, Quederni M, Paganelli R, Paris K, Pignata C, Plebani A, Qamar FN, Qureshi S, Radhakrishnan N, Rezaei N, Rosario N, Routes J, Sanchez B, Sediva A, Seppanen MRJ, Serrano EG, Shcherbina A, Singh S, Siniah S, Spadaro G, Tang M, Vinet AM, Volokha A, Sullivan KE, Condino Neto A. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world [Internet]. World Allergy Organization Journal. 2019 ; 12 9 .[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.waojou.2019.100018

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024